Hyperuricemia Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Hyperuricemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

GoutGouty ArthritisHyperuricemia+4 more
Arthrosi Therapeutics25 enrolled8 locationsNCT07116746
Recruiting
Not Applicable

Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)

HypertensionHyperuricemiaHyperglycemia+2 more
China National Center for Cardiovascular Diseases100 enrolled1 locationNCT07400549
Recruiting
Phase 1Phase 2

A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease

HyperuricemiaHypouricemia, Renal
Intelligem Therapeutics Australia Pty Ltd.60 enrolled6 locationsNCT06310967
Recruiting
Phase 4

Effect of Dotinurad in Hyperuricemia With Hypertension

HypertensionHyperuricemia or Gout
Saga University360 enrolled1 locationNCT06834230
Recruiting

This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Order to Evaluate the Need of Adjuvant Uric Acid Lowering Therapy

HyperuricemiaHemodialysis
Sohag University100 enrolled1 locationNCT07144332
Recruiting

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Diabetes MellitusInsulin Sensitivity/ResistanceObesity+16 more
Osaka Metropolitan University2,000 enrolled1 locationNCT06694012
Recruiting

Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases

Diabetes MellitusObesityHypertension+2 more
Peking Union Medical College Hospital200 enrolled1 locationNCT05476627